zaleplon has been researched along with sch 16134 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Yamadera, H | 1 |
2 review(s) available for zaleplon and sch 16134
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recent progress in development of hypnotic drugs].
Topics: Acetamides; Animals; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Female; Humans; Hypnotics and Sedatives; Learning; Male; Memory; Pregnancy; Pyridines; Pyrimidines; Sleep Wake Disorders; Zolpidem | 1998 |